GRDN Stock Overview

Profile

Full Name:

Guardian Pharmacy Services, Inc.

Sector:

Healthcare

Industry:

Medical Care Facilities

Country:

United States

IPO:

April 21, 2016

Indexes:

Not included

Website:

http://guardianpharmacy.com

Description:

Guardian Pharmacy Services is a network of independent pharmacies that provide personalized healthcare and medication management services to communities across the United States. They focus on improving patient outcomes and enhancing the pharmacy experience.

Key Details

Price

$21.49

Market Cap

$1.36 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.05 B(+15.10% YoY)

Annual EPS

$0.39(-32.53% YoY)

PE Ratio

-

Annual ROE

35.20%

Annual Debt To Equity

-

Beta

0.89

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 15, 24 Truist Securities
Buy
Oct 22, 24 Stephens & Co.
Overweight
Oct 21, 24 Truist Securities
Buy

Screeners with GRDN included

US stocks
Most recommended stocks
Best performing stocks last 3 months
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Medical Care Facilities industry
Stocks above SMA 200

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$21.49
GRDN price is $21.49

Price All-time High

$25.17
GRDN price is currently -14.62% below its historical high of $25.17

Price Analysts Target

$24.00
GRDN price is currently -10.46% lower than the consensus analysts' forecast

Price Today Change

-3.37%
GRDN price is down -3.37% today

Price YTD Change

+6.07%
GRDN price is up +6.07% since January 1st

Price 3-Year Change

-
GRDN price 3-year change is unknown

Market cap

Market Cap

$1.36 B
GRDN market capitalization is $1.36 billion

Market Cap 3-Year Change

-
GRDN market capitalization 3-year change is unknown

Market Cap All-time High

$1.59 B
GRDN market capitalization is currently -14.62% below its historical high of $1.59 billion

Market Cap Sector Rank

77.55%
GRDN market capitalization is higher than 77.55% of companies in Healthcare sector

Technical

Beta

0.89
GRDN beta is 0.89

200-day SMA

$20.68
GRDN price is currently +3.93% above its 200-day simple moving average

14-day RSI

53.22
GRDN 14-day relative strength index is 53.22

30-day Relative Volume

0.58
GRDN 30-day relative volume is 0.58

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.05 B
GRDN annual revenue is $1.05 billion

Annual Revenue Analysts Estimate

$1.21 B
GRDN annual revenue is currently -13.57% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+15.1%
GRDN annual revenue is up +15.1% year-on-year

Annual Revenue Sector Rank

80.59%
GRDN annual revenue is higher than 80.59% of companies in Healthcare sector

Profit

Annual Gross Profit

$208.31 M
GRDN annual gross profit is $208.31 million

Annual Gross Margin

19.91%
GRDN annual gross profit margin is 19.91%

Annual Operating Profit

$40.95 M
GRDN annual operating income is $40.95 million

Annual Operating Margin

3.91%
GRDN annual operating profit margin is 3.91%

Annual Net Income

$23.90 M
GRDN annual net profit is $23.90 million

Annual Net Margin

2.28%
GRDN annual net profit margin is 2.28%

EPS

Annual EPS

$0.39
GRDN annual earnings per share is $0.39

Annual EPS Analysts Estimate

$0.84
GRDN annual earnings per share is currently -53.24% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-32.53%
GRDN annual earnings per share is down -32.53% year-on-year

Annual EPS Sector Rank

86.4%
GRDN annual earnings per share is higher than 86.4% of companies in Healthcare sector

ROA & ROE

Annual ROA

9.07%
GRDN annual return on assets is 9.07%

Annual ROE

35.20%
GRDN annual return on equity is 35.20%

EBIT & EBITDA

Annual EBIT

$40.58 M
GRDN annual earnings before interest & taxes is $40.58 million

Annual EBITDA

$58.81 M
GRDN annual EBITDA is $58.81 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
GRDN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
GRDN price to earnings ratio is unknown

PB Ratio

PB Ratio

10.66
GRDN price to book ratio is 10.66

PB Ratio Sector Rank

91.58%
GRDN price to book ratio is higher than 91.58% of companies in Healthcare sector

PS Ratio

PS Ratio

1.52
GRDN price to sales ratio is 1.52

PS Ratio Sector Rank

32.47%
GRDN price to sales ratio is higher than 32.47% of companies in Healthcare sector

Enterprise value

Enterprise Value

$1.40 B
GRDN enterprise value is $1.40 billion

Enterprise Value Sector Rank

77.28%
GRDN enterprise value is higher than 77.28% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-22.30
GRDN EV/EBITDA is -22.30

EV/EBITDA Sector Rank

7.03%
GRDN EV/EBITDA is higher than 7.03% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.94
GRDN annual current ratio is 0.94

Annual Quick Ratio

0.67
GRDN annual quick ratio is 0.67

Leverage

Annual Debt To Equity

-
GRDN annual debt to equity ratio value is unknown

Annual Interest Coverage Ratio

14.19
GRDN annual interest coverage ratio is 14.19

Risk & Stability

Piotroski F-Score

-
GRDN piotroski f-score value is unknown

Altman Z-Score

-
GRDN altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$271.17 M
GRDN annual total assets is $271.17 million

Annual Non Current Assets

$141.56 M
GRDN annual long term assets is $141.56 million

Annual Current Assets

$129.60 M
GRDN annual total current assets is $129.60 million

Annual Cash & Cash Equivalents

$752.00 K
GRDN annual cash & cash equivalents is $752.00 thousand

Equity

Annual Book Value

$28.21 M
GRDN annual book value is $28.21 million

Annual Working Capital

-$8.41 M
GRDN annual working capital is -$8.41 million

Liabilities

Annual Total Liabilities

$211.31 M
GRDN annual total liabilities is $211.31 million

Annual Total Long Term Liabilities

$73.29 M
GRDN annual total long term liabilities is $73.29 million

Annual Current Liabilities

$138.01 M
GRDN annual total current liabilities is $138.01 million

Annual Accounts Payable

$85.60 M
GRDN annual accounts payable is $85.60 million

Debt

Annual Total Debt

$61.00 M
GRDN annual total debt is $61.00 million

Annual Total Debt 1-Year Change

+7.37%
GRDN annual total debt is up +7.37% year-on-year

Annual Long Term Debt

$41.80 M
GRDN annual long term debt is $41.80 million

Annual Short Term Debt

$19.21 M
GRDN annual short term debt is $19.21 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$1.01 B
GRDN annual total expenses is $1.01 billion

Annual Operating Expenses

$167.36 M
GRDN annual total operating expenses is $167.36 million

Annual Cost Of Goods Sold

$837.88 M
GRDN annual cost of goods sold is $837.88 million

Annual SGA

$167.36 M
GRDN annual SGA is $167.36 million

Annual D&A

$18.23 M
GRDN annual depreciation & amortization is $18.23 million

Annual Interest Expense

$2.86 M
GRDN annual interest expense is $2.86 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$70.82 M
GRDN annual cash flow from operations is $70.82 million

Annual CFO 1-Year Change

+45.95%
GRDN annual cash flow from operations is up +45.95% year-on-year

Annual CFI

-$13.44 M
GRDN annual cash flow from investing activities is -$13.44 million

Annual CFI 1-Year Change

+24.91%
GRDN annual cash flow from investing activities is up +24.91% year-on-year

Annual CFF

-$57.23 M
GRDN annual cash flow from financing activities is -$57.23 million

Annual CFF 1-Year Change

-27.11%
GRDN annual cash flow from financing activities is down -27.11% year-on-year

Free CashFlow

Annual FCF

$56.26 M
GRDN annual free cash flow is $56.26 million

Annual FCF 1-Year Change

+77.2%
GRDN annual free cash flow is up +77.2% year-on-year

CAPEX

Annual CAPEX

$14.56 M
GRDN annual capital expenditures is $14.56 million

Annual CAPEX 1-Year Change

-13.2%
GRDN annual capital expenditures is down -13.2% year-on-year

Institutional Ownership

Similar stocks

VIR logo
Vir Biotechnology (VIR)
SYRE logo
Spyre Therapeutics (SYRE)
INMD logo
InMode (INMD)
LQDA logo
Liquidia (LQDA)
Indivior (INDV)
RXST logo
RxSight (RXST)
NRIX logo
Nurix Therapeutics (NRIX)
Fortrea Holdings (FTRE)
AORT logo
Artivion (AORT)
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
GRDN
benzinga.comOctober 21, 2024

Truist Securities has initiated coverage on Guardian Pharmacy Services, Inc GRDN, which operates long-term care pharmacies that facilitate the full lifecycle of pharmacy administration and associated consultative services for residents of long-term healthcare facilities (LTCFs).

FAQ

  • What is the ticker symbol for Guardian Pharmacy Services?
  • Does Guardian Pharmacy Services pay dividends?
  • What sector is Guardian Pharmacy Services in?
  • What industry is Guardian Pharmacy Services in?
  • What country is Guardian Pharmacy Services based in?
  • When did Guardian Pharmacy Services go public?
  • Is Guardian Pharmacy Services in the S&P 500?
  • Is Guardian Pharmacy Services in the NASDAQ 100?
  • Is Guardian Pharmacy Services in the Dow Jones?
  • When does Guardian Pharmacy Services report earnings?
  • Should I buy Guardian Pharmacy Services stock now?

What is the ticker symbol for Guardian Pharmacy Services?

The ticker symbol for Guardian Pharmacy Services is NYSE:GRDN

Does Guardian Pharmacy Services pay dividends?

No, Guardian Pharmacy Services does not pay dividends

What sector is Guardian Pharmacy Services in?

Guardian Pharmacy Services is in the Healthcare sector

What industry is Guardian Pharmacy Services in?

Guardian Pharmacy Services is in the Medical Care Facilities industry

What country is Guardian Pharmacy Services based in?

Guardian Pharmacy Services is headquartered in United States

When did Guardian Pharmacy Services go public?

Guardian Pharmacy Services's initial public offering (IPO) was on April 21, 2016

Is Guardian Pharmacy Services in the S&P 500?

No, Guardian Pharmacy Services is not included in the S&P 500 index

Is Guardian Pharmacy Services in the NASDAQ 100?

No, Guardian Pharmacy Services is not included in the NASDAQ 100 index

Is Guardian Pharmacy Services in the Dow Jones?

No, Guardian Pharmacy Services is not included in the Dow Jones index

When does Guardian Pharmacy Services report earnings?

The date for Guardian Pharmacy Services's next earnings report has not been announced yet

Should I buy Guardian Pharmacy Services stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions